Diclofenac Sandoz

Quick links to important sections

Diclofenac Sandoz

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclofenac Sandoz

Quick Facts

Property Description
Active Ingredient Diclofenac (Sodium or Potassium salt)
Form Tablets, injections, gels, suppositories, patches
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
General Purpose Reduction of pain, inflammation, and fever
Origin Synthetic (Phenylacetic acid derivative)

What Type of Medicine is Diclofenac Sandoz?

Diclofenac Sandoz is a pharmaceutical product containing the active substance Diclofenac, which is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification identifies its core role as an anti-inflammatory agent, an analgesic agent (pain reliever), and an antipyretic agent (fever reducer). Diclofenac is a synthetic compound derived from phenylacetic acid. The Sandoz designation indicates the brand under which this clinically recognized generic substance is supplied, often ensuring wide availability. This structural and pharmacological identity concentrates the therapeutic effect on managing inflammatory conditions.


Diclofenac Sandoz: Composition and Available Forms

The active ingredient in this medicine is Diclofenac, frequently prepared as its sodium or potassium salt. Diclofenac Sandoz is available in a variety of pharmaceutical preparations to facilitate different routes of administration. These forms include oral options such as conventional and enteric-coated tablets (a composition feature designed to delay absorption), as well as non-oral products for local action, such as topical gels and transdermal patches. Diclofenac belongs to the family of NSAIDs and is available in various approved formulations. This versatility in forms ensures the medicine can be delivered for either systemic absorption (treating issues throughout the body) or highly localized action.


What is the General Therapeutic Purpose of Diclofenac?

The general therapeutic purpose of Diclofenac is to mitigate the core biological processes that lead to pain and inflammation. It functions as a cyclooxygenase inhibitor, curtailing the production of inflammatory mediators known as prostaglandins. Diclofenac exerts a significant inhibitory effect on prostaglandin synthesis, which is the primary mechanism behind its anti-inflammatory action. This confirms that the medicine works by targeting the root biological cause of swelling and pain. This specific action is why the medicine provides the core beneficial effects of analgesia, reduction of swelling, and control of fever in inflammatory conditions, such as the symptomatic relief often required for musculoskeletal discomfort.

Regulatory References

  1. NIH/NCBI Bookshelf article on Diclofenac Mechanism of Action

What side effects are possible with Diclofenac Sandoz?

Possible Side Effects and Safety Information

Diclofenac Sandoz, a nonsteroidal anti-inflammatory drug (NSAID), is associated with officially documented risks, particularly concerning the cardiovascular and gastrointestinal systems. These risks are generally considered to be dose- and duration-dependent, meaning the risk increases with higher doses or longer use.


Serious and Clinically Significant Adverse Reactions

Cardiovascular Thrombotic Events: Use of this medicine can increase the risk of serious, potentially fatal, cardiovascular thrombotic events such as myocardial infarction (heart attack) and stroke. The risk is increased in patients with pre-existing heart disease or significant cardiovascular risk factors.

Gastrointestinal Adverse Events: Diclofenac is associated with a risk of serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestine, which can be fatal and may occur without warning symptoms.

Hepatic and Renal Toxicity: Rare but serious cases of liver injury (hepatotoxicity), including liver failure, and severe renal impairment have been reported. Elevated liver enzymes are a common adverse effect.


Adverse Reaction Classification

Frequency Examples of Adverse Reactions (System-Organ Class)
Common Headache, dizziness (Nervous System); Nausea, vomiting, diarrhea, abdominal pain, dyspepsia (Gastrointestinal System); Elevated liver enzymes (Hepatic System).
Uncommon Gastrointestinal hemorrhage, ulceration (Gastrointestinal System).
Very Rare Serious allergic reactions (including anaphylaxis, angioedema); Serious skin reactions (e.g., Stevens-Johnson syndrome); Aseptic meningitis; Severe heart failure.

Safety Restrictions and Considerations

Contraindications: Use is strictly contraindicated in patients with established congestive heart failure (NYHA class II-IV), established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease. It is also contraindicated in the setting of coronary artery bypass graft (CABG) surgery and in patients with active gastrointestinal ulceration or bleeding.

Pregnancy: The use of systemic NSAIDs like Diclofenac Sandoz is contraindicated from about 30 weeks of gestation (third trimester) due to the risk of premature closure of the fetal ductus arteriosus and fetal renal dysfunction.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Diclofenac Sandoz involves the risk of systemic toxicity. Documented acute manifestations may include gastrointestinal disorders such as vomiting, diarrhoea, or haemorrhage, alongside Central Nervous System effects like headache, dizziness, lethargy, or disorientation.

A large overdosage, which is often dose-dependent, can lead to severe and potentially life-threatening outcomes. These complications, which require urgent management, include acute renal failure, significant hepatic damage, and respiratory or cardiac compromise. Individuals with pre-existing renal or hepatic impairment are noted in official labeling to be at increased risk of severe organ damage following overdosage.

Because the regulatory documents state that no specific antidote is known for Diclofenac toxicity, the official guidance mandates that individuals must seek immediate medical attention for any suspected overdosage. The required medical approach centers on symptomatic and supportive treatment. Depending on the time since ingestion, procedures such as the administration of activated charcoal or gastric lavage may be considered by medical professionals, with intensive monitoring being necessary.

Therapeutic Uses of Diclofenac Sandoz

What Diclofenac Sandoz Treats: Main Uses and Benefits

Diclofenac Sandoz is used in situations involving certain distressing symptoms, and is applied across domains where additional symptomatic support is needed. It is commonly used to help manage symptoms related to inflammatory or irritative states. This medication is relevant when supportive symptom management is appropriate, and contributes to easing the overall symptom load.

The medicine is relevant in conditions involving episodic or fluctuating manifestations, and is commonly used to help manage the symptoms of chronic conditions like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It also addresses acute episodes such as gouty arthritis flare-ups, sprains and strains, and specific pain from primary dysmenorrhea or postoperative discomfort.

“It is often used during phases when symptoms become more noticeable and supportive relief is needed.”

This symptomatic relief is relevant when supportive symptom management is appropriate, particularly when symptoms interfere with daily functioning. The medication may assist in addressing symptom clusters that may become intense or disruptive, specifically joint swelling, stiffness, and chronic pain.


Quick Fact: Symptomatic Support

Property Description
Core Symptom Domains Symptoms related to physical discomfort, inflammation, and fever
Typical Conditions Conditions involving acute or disruptive episodes, such as Arthritis, Acute Injury, Gout, Dysmenorrhea
Benefit Focus Contributes to easing symptom load and supports comfort
Common Clinical Context Applied in clinical settings that involve acute or unstable symptom patterns

Eligibility and Restrictions for Use

Diclofenac Sandoz eligibility is defined by regulatory agencies based on pre-existing health status and life stage. The medicine is contraindicated in several key populations. Absolute non-eligibility applies to patients with known hypersensitivity to diclofenac, aspirin, or other NSAIDs, including those with aspirin-sensitive asthma. Use is also prohibited in patients with active gastrointestinal ulceration, bleeding, or perforation. The medicine is strictly contraindicated in individuals with established serious cardiovascular disease, such as congestive heart failure (NYHA Class II–IV), ischemic heart disease, or in the perioperative setting of Coronary Artery Bypass Graft (CABG) surgery. Furthermore, use is prohibited in patients with severe hepatic or renal failure.

Age-related and reproductive restrictions are also documented. The medicine is strictly contraindicated during the last trimester of pregnancy and is not recommended while breastfeeding. Use is also not recommended for women attempting to conceive. Use in children and adolescents below 14 or 18 years (depending on formulation) is generally not established or not recommended. Elderly patients are classified as requiring particular caution, mandating the use of the lowest effective dose for the shortest possible duration.

What should I know about interactions with other medicines?

Diclofenac Sandoz Interactions with other medicines and products

Diclofenac Sandoz interactions are officially documented and classified by regulatory authorities based on their potential to alter systemic exposure or produce additive pharmacodynamic effects. Formal restrictions dictate that the product is contraindicated for treating perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and should not be co-administered with other systemic NSAIDs due to the documented potential for additive adverse events.

Pharmacokinetic interactions are officially described for drugs affecting metabolic pathways. Co-administration with strong CYP2C9 inhibitors, such as Voriconazole, results in a significant increase in Diclofenac's plasma concentration. Conversely, Diclofenac can reduce the renal clearance and elevate the plasma levels of co-medications like Lithium, Methotrexate, and Digoxin.

Pharmacodynamic interactions primarily involve a synergistic increase in risk. Combining Diclofenac with anticoagulants, SSRIs, or corticosteroids increases the officially recognized risk of gastrointestinal bleeding and ulceration. The product may also diminish the therapeutic effects of Diuretics and ACE-Inhibitors. Specific caution is documented for co-use with these medicines in elderly, volume depleted, or renal impaired patients due to a heightened risk of renal function deterioration. Additionally, official documents note that alcohol consumption may increase the risk of GI bleeding.

Mechanism of Action

How Diclofenac Sandoz Works

Diclofenac is a nonsteroidal agent whose primary action is the modulation of chemical signaling involving the arachidonic acid cascade. Its mechanism is focused on targeted pathway interference at the molecular level, leading to predictable physiological adjustments.

Inhibition of the Prostaglandin Synthesis Pathway

The drug acts by competitively inhibiting the Cyclooxygenase (COX-1 and COX-2) enzymes, which are crucial for converting arachidonic acid into prostanoid mediators. This core molecular action suppresses the formation of prostaglandins, thereby reducing the subsequent chemical output of the inflammatory response.

Modulation of Nociception and Thermoregulation Signaling

The suppression of prostaglandin synthesis initiates a mechanistic cascade that affects two distinct regulatory systems. In peripheral tissues, reduced PGE2 prevents the chemical sensitization of nociceptors, thereby modulating the magnitude of nociceptive signal propagation. In the central nervous system, this mechanism acts on the hypothalamus to reverse the PGE2 -induced elevation of the body's thermoregulatory set-point, influencing the set-point toward normalization.

Dosage and Administration Information

How to Use Diclofenac Sandoz: Administration Guidelines

The usage of Diclofenac is governed by the principle of administering the lowest effective dose for the shortest duration possible. This approach structures the entire dosing regimen across its approved administration routes and forms.


Administration Routes and Dose Management

Diclofenac is available in multiple administration routes, including oral (tablets, capsules), topical (gel, solution), rectal (suppositories), and parenteral (injection/infusion) delivery.

Administration Route Standard Adult Dose Range Frequency/Timing Preparation/Condition
Oral (Delayed-Release) 75 mg to 150 mg per day, divided. Typically two or three times daily (b.i.d. or t.i.d.). Tablets must be swallowed whole (not crushed/chewed) and are often directed to be taken preferably before meals.
Oral (Extended-Release) Up to 100 mg per day. Typically once daily (q.d.). Must be swallowed whole.
Intravenous (IV) Up to 150 mg per 24 hours (for post-operative pain). Administered as an infusion over a period of 30 minutes to 2 hours. Must be diluted and buffered with sodium bicarbonate solution immediately before infusion.

Population and Procedural Rules

Specific guidance applies to certain patient populations. For older adults, the recommendation is to initiate treatment using the lowest effective dosage. For children over 14 years old, the maximum daily dose is often limited to 75 mg in divided doses, with lower strengths recommended for younger pediatric patients.

In the event a dose is missed, the general procedure is to skip the missed dose if it is near the time for the next scheduled dose. The course of treatment via injection is typically limited to no more than two days, with subsequent treatment, if necessary, to continue using oral or rectal forms.

Recent Clinical Evidence

Diclofenac Sandoz: Recent Clinical Evidence

Research Evidence for Chronic Inflammatory Joint Conditions

Research examined Diclofenac in studies exploring how symptoms change over time in Osteoarthritis (OA) and Rheumatoid Arthritis (RA), which are conditions characterized by fluctuating or episodic manifestations and marked by functional limitations. The evidence primarily comes from short-term, randomized controlled trials (RCTs) that included the study of Diclofenac (oral and topical formulations) alongside a placebo or other active-comparator treatments. Researchers monitored outcomes related to physical discomfort and daily functioning.

Trials tracked measurements of symptom outcomes over observation periods that typically lasted between four and twelve weeks. The research in both OA and RA provides observations of short-term symptom patterns. However, research exploring the effects of this medicine on long-term structural joint changes or the condition's progression was not the primary focus of these efficacy trials.

Evidence for Acute Pain and Symptom Management

Research was conducted in trials assessing short-term or episodic symptom patterns, such as Primary Dysmenorrhea (menstrual cramps) and various forms of Acute Musculoskeletal Pain. Studies focused on episodes where symptoms become more noticeable, measuring outcomes related to symptom intensity or variability over very short observation intervals (e.g., a single day or menstrual cycle).

Data reported in studies indicate patterns related to outcomes capturing phases of heightened symptom activity. Because the research is strictly focused on acute use, there is limited information for outcomes related to long-term or repeated monthly administration for these conditions.

Limitations and Research Gaps in the Evidence

A synthesis of the evidence base indicates several key limitations. Follow-up durations in efficacy trials were generally limited to a few months. Evidence quality varies across studies, and certainty remains low regarding outcomes beyond the specific conditions under which the studies were conducted. Research provides context about group patterns but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Diclofenac Sandoz (FAQ)

Q: Is Diclofenac Sandoz considered a type of narcotic or opioid?

A: According to regulatory documents, Diclofenac is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification identifies it as a distinct class of medication, separate from narcotics or opioid agents.


Q: How long after taking Diclofenac Sandoz should I expect to feel relief?

A: Regulatory data indicates that the onset of action for some oral non-gel formulations is typically reported as being within 30 minutes. However, the time the drug takes to reach its highest level in the bloodstream and provide maximum relief may vary depending on the specific product formulation.


Q: Is it common for Diclofenac Sandoz to cause stomach upset?

A: Official safety information lists common adverse reactions that include gastrointestinal symptoms. These may involve stomach upset, such as nausea, vomiting, diarrhea, abdominal pain, or dyspepsia (indigestion).


Q: What happens if I miss a scheduled time to take Diclofenac Sandoz?

A: Regulatory instructions generally specify that a patient should skip the missed dose entirely if the time for the next scheduled dose is near. The patient is then advised to continue with their regular dosing schedule.

--UNSURE HOW TO FIX THE CODE, BUT THIS NEEDS TO BE ADDED, BECAUSE IT WAS IN PREVIOUS PROMPT--

Q: Is the Sandoz brand of diclofenac considered a generic medication?

A: Diclofenac is recognized as a clinically available generic substance within the Nonsteroidal Anti-inflammatory Drug (NSAID) class. Sandoz is the brand name of the company that supplies this substance as a finished pharmaceutical product.


Q: What should a patient do if they experience unusual bleeding while on Diclofenac Sandoz?

A: Official warnings state that signs of serious gastrointestinal bleeding should prompt immediate attention. These signs include black, bloody, or tarry stools, or vomit that looks like coffee grounds. These signs should prompt a patient to seek medical attention immediately, as noted in official warnings.


Q: Can I crush or split the Diclofenac Sandoz tablets?

A: Regulatory instructions for certain oral formulations, particularly delayed-release and extended-release tablets, state they must be swallowed whole. These forms should not be crushed, chewed, or split.


Q: What is the risk of gastrointestinal issues with Diclofenac Sandoz compared to other pain relievers?

A: Official evidence indicates that Diclofenac is generally associated with a potentially higher risk of serious gastrointestinal adverse events (like bleeding and ulceration) compared to some other nonsteroidal anti-inflammatory drugs.


Q: What is the difference between Diclofenac Sandoz and regular ibuprofen?

A: Both are classified as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), but they are distinct chemical compounds with differences in their profiles. Official evidence suggests that Diclofenac is generally associated with a potentially higher risk of cardiovascular and gastrointestinal adverse events compared to ibuprofen.


Q: Does Diclofenac Sandoz come in different strengths?

A: Yes, Diclofenac products are officially available in multiple oral strengths, commonly including 25 mg, 50 mg, 75 mg, and 100 mg tablets. Various topical forms are also available in different concentrations.


Q: Are there any specific foods or drinks to avoid when using Diclofenac Sandoz?

A: Official warnings state that alcohol consumption can increase the recognized risk of serious gastrointestinal bleeding associated with diclofenac. Food may delay the rate at which the drug is absorbed, but generally does not affect the total amount absorbed.


Q: What is the longest period of time people typically take Diclofenac Sandoz for?

A: Diclofenac is indicated for both acute (short-term) and long-term use, such as for the ongoing management of symptoms related to chronic conditions like osteoarthritis and rheumatoid arthritis. The duration of treatment is guided by the specific condition.


Q: Can Diclofenac Sandoz be used by patients who are 65 years old or older?

A: Regulatory documents approve the use of this medicine in older adults. Regulatory documents state that treatment in older adults is advised to begin using the lowest effective dose for the shortest time possible, due to a potentially heightened risk of adverse events.


Q: What kind of research has been done on the long-term use of this drug?

A: Clinical trials of NSAIDs, including diclofenac, have examined use for up to three years for chronic conditions like arthritis. Official reviews caution that the evidence quality and certainty regarding long-term safety can vary across different studies.


Q: Does Diclofenac Sandoz interact with any common over-the-counter supplements?

A: Regulatory information indicates that combining diclofenac with certain non-prescription supplements, such as glucosamine, omega-3 fatty acids, and Vitamin E, may require monitoring or caution.


Q: What are the signs that someone may be allergic to Diclofenac Sandoz?

A: Signs of a serious allergic reaction may include hives (urticaria), facial swelling, asthma (such as wheezing or shortness of breath), and severe skin rash. These signs should prompt a person to seek medical attention immediately, as noted in official warnings.


Q: Does alcohol consumption increase the risk of side effects from Diclofenac Sandoz?

A: Yes, official warnings state that alcohol use can increase the recognized risk of serious gastrointestinal bleeding and ulceration associated with diclofenac.


Q: What is the purpose of the enteric coating on some forms of Diclofenac Sandoz?

A: The enteric coating on some tablets is a formulation feature designed to prevent the tablet from dissolving in the stomach. This helps to reduce stomach irritation and delays the absorption of the medication until it reaches the small intestine.


Q: Can people with diabetes safely take Diclofenac Sandoz?

A: Diclofenac may interact with a class of diabetes medications known as sulfonylureas. This noted interaction may require monitoring or dose adjustments to be implemented by a healthcare professional.


Q: Is there a maximum number of days Diclofenac Sandoz should be taken consecutively?

A: For administration via injection, use is typically limited to no more than two days. For oral use, the general regulatory principle is to use the product for the shortest duration possible to manage symptoms effectively.


Q: Are there different forms of Diclofenac (like gels or patches) that are also Sandoz brand?

A: Diclofenac is available in various pharmaceutical preparations, including gels, topical solutions, and patches. The Sandoz brand has been associated with specific ophthalmic and other non-oral forms on regulatory registers.


Q: Does Diclofenac Sandoz affect liver enzyme levels?

A: Yes, official safety information lists elevated serum aminotransferase levels (liver enzymes) as a common adverse reaction. Rare but serious cases of severe liver injury (hepatotoxicity) have also been reported with use.


Q: Can taking Diclofenac Sandoz cause headaches?

A: Yes, headache is listed as a common adverse reaction in the official safety information for diclofenac. Official information generally advises reporting any severe or persistent symptoms to a healthcare professional.


Q: Does the medicine come with a specific patient information leaflet?

A: Regulatory requirements for prescription medicines mandate that the product be dispensed with a Patient Information Leaflet (PIL) or equivalent labeling, such as a Medication Guide, which provides key information about its use and risks.


Q: How long does the effect of one dose of Diclofenac Sandoz typically last?

A: The elimination half-life of the drug is approximately 1.2 to 2 hours. However, the therapeutic effect can often be observed for a longer duration due to the drug accumulating in tissues, such as the site of inflammation.


Q: Is it possible for Diclofenac Sandoz to cause mood changes or depression?

A: Serious adverse reactions reported in post-marketing surveillance for diclofenac include changes in mood. Official information has noted reports of symptoms such as anxiety and depression.


Q: Do regulatory agencies classify Diclofenac Sandoz as prescription-only?

A: Systemic forms of diclofenac, such as oral tablets and injections, are generally classified as prescription-only in most regions due to associated risks. However, topical forms may be available without a prescription in some areas.


Q: Is Diclofenac Sandoz suitable for children?

A: Use in children and adolescents is not established or not recommended for all formulations. Specific low-dose forms may be approved for use in children over a certain age (e.g., 12 months for some arthritis conditions), depending on the country and formulation.

How should Diclofenac Sandoz be stored and disposed of?

How to Store and Dispose of Diclofenac Sandoz?

Diclofenac Sandoz tablets must be stored according to regulatory specifications to maintain product integrity. The medicine must be kept in its original container in a cool, dry place where the temperature stays below 25 C and should be protected from light and dampness. It is crucial to keep the medicine out of the reach of children.

Official Disposal Requirements

To dispose of expired or unused medicine, do not throw it into household garbage or flush it down the toilet or sink. Instead, the product must be returned to the pharmacist for proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclofenac Sandoz found in:

A-Z Index: